Axsome Therapeutics
AXSM • NASDAQ
Axsome Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Herriot Tabuteau, with a market cap of $8.0B.
CEOHerriot Tabuteau
Next Earnings
Upcoming earnings announcement for Axsome Therapeutics
Date
Monday, May 4, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.78
Revenue Estimate
$193.0M
Earnings History
Past 12 earnings reports for Axsome Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 23, 2026 | Q4 2025 | -$0.56Est: -$0.72 | +22.2% | $196.0MEst: $193.2M | +1.5% |  10-K |
| Nov 3, 2025 | Q3 2025 | -$0.68Est: -$0.87 | +21.8% | $171.0MEst: $163.4M | +4.6% | 10-Q |
| Aug 4, 2025 | Q2 2025 | -$0.47Est: -$1.05 | +55.2% | $150.0MEst: $138.7M | +8.2% | 10-Q |
| May 5, 2025 | Q1 2025 | -$0.68Est: -$1.35 | +49.6% | $121.5MEst: $119.3M | +1.8% | 10-Q |
| Feb 18, 2025 | Q4 2024 | -$0.80Est: -$0.99 | +19.2% | $118.8MEst: $117.8M | +0.8% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.49Est: -$1.41 | +65.2% | $104.8MEst: $98.1M | +6.8% | 10-Q |
| Aug 5, 2024 | Q2 2024 | -$1.12Est: -$1.33 | +15.8% | $87.2MEst: $86.9M | +0.3% | 10-Q |
| May 6, 2024 | Q1 2024 | -$1.00Est: -$1.21 | +17.4% | $75.0MEst: $73.5M | +2.1% | 10-Q |
| Feb 20, 2024 | Q4 2023 | -$0.73Est: -$1.15 | +36.5% | $71.5MEst: $67.7M | +5.7% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$1.32Est: -$1.19 | -10.9% | $57.8MEst: $55.8M | +3.7% | — |
| Aug 7, 2023 | Q2 2023 | -$1.54Est: -$1.24 | -24.2% | $46.7MEst: $40.2M | +16.2% | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.26Est: -$1.04 | +75.0% | $94.6MEst: $26.1M | +262.8% | — |